NCT00231478View on ClinicalTrials.gov

A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Post-Operative Nausea and Vomiting
Interventions
DRUG

granisetron

20 micrograms intravenously (iv) 15 min prior to end of surgery

DRUG

granisetron

40 micrograms intravenously (iv) 15 min prior to end of surgery

Trial Locations (11)

15213

Pittsburgh

21287

Baltimore

30322

Atlanta

33136

Miami

37232

Nashville

46223

Indianapolis

75235

Dallas

93720

Fresno

94305-5118

Stanford

06106

Hartford

02114

Boston

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00231478 - A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy | Biotech Hunter | Biotech Hunter